Department of Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.
Autophagy. 2021 Dec;17(12):4083-4101. doi: 10.1080/15548627.2021.1901204. Epub 2021 Mar 25.
Chemotherapy is currently the main treatment for unresectable or advanced postoperative gastric cancers. However, its efficacy is negatively affected by the occurrence of chemoresistance, which severely affects patient prognosis. Recently, dysregulation in autophagy has been suggested as a potential mechanism for chemoresistence, and long noncoding RNA (lncRNA) also shows its regulatory role in cancer drug resistance. Using RNA sequencing, we found that lncRNA was highly expressed in drug-resistant gastric cancer cells. In-vitro and in-vivo experiments showed that activated autophagy and induced drug resistance in gastric cancer cells by targeting ATG14. Bioinformatics and experimental results showed that regulated the expression of ATG14 through direct binding to enhance stabilization of mRNA and via blocking the degradation of mRNA through competitively binding with microRNA (miRNA) . Therefore, increased the expression of ATG14, contributing to activation of autophagy and chemoresistance. Furthermore, it was confirmed that and ATG14 were highly expressed in gastric cancer patients resistant to chemotherapy, and this was closely associated with patient prognosis. In conclusion, is involved in the regulation of autophagy and chemoresistance in gastric cancer cells by targeting ATG14. It may be a suitable new target for enhancing chemosensitivity and improving prognosis. 3-MA: 3-methyladenine; 5-Fu: 5-fluorouracil; ATG: autophagy related; C-CASP3: cleaved caspase 3; C-CASP7: cleaved caspase 7; C-PARP: cleaved PARP; CQ: chloroquine; CR: complete response; DIG: digoxigenin; ESR1: estrogen receptor 1; FBS: fetal bovine serum; FISH: fluorescence in situ hybridization; IHC: immunohistochemistry; ISH: in situ hybridization; lncRNA: long noncoding RNA; miRNA: microRNA; MUT: mutant; NC: negative control; OXA: oxaliplatin; PBS: phosphate-buffered saline; PD: progressive disease; PFA: paraformaldehyde; PR: partial response; qPCR: quantitative polymerase chain reaction; RAPA: rapamycin; SD: stable disease; TEM: transmission electron microscopy; WT: wild type.
化疗是目前不可切除或术后晚期胃癌的主要治疗方法。然而,其疗效受到化疗耐药的影响,严重影响患者的预后。最近,自噬的失调被认为是化疗耐药的潜在机制,长链非编码 RNA(lncRNA)也显示出其在癌症药物耐药性中的调节作用。通过 RNA 测序,我们发现 lncRNA 在耐药性胃癌细胞中高表达。在体外和体内实验中,我们发现 lncRNA 通过靶向 ATG14 激活自噬并诱导胃癌细胞耐药。生物信息学和实验结果表明,lncRNA 通过直接结合调节 ATG14 的表达,增强其 mRNA 的稳定性,并通过与 microRNA(miRNA)竞争性结合来阻断其 mRNA 的降解。因此,lncRNA 通过上调 ATG14 的表达,促进自噬的激活和化疗耐药。此外,我们证实,lncRNA 和 ATG14 在对化疗耐药的胃癌患者中高表达,并且与患者的预后密切相关。总之,lncRNA 通过靶向 ATG14 参与调节胃癌细胞的自噬和化疗耐药。它可能是增强化疗敏感性和改善预后的合适新靶点。3-MA:3-甲基腺嘌呤;5-Fu:5-氟尿嘧啶;ATG:自噬相关;C-CASP3:裂解的 caspase 3;C-CASP7:裂解的 caspase 7;C-PARP:裂解的 PARP;CQ:氯喹;CR:完全缓解;DIG:地高辛;ESR1:雌激素受体 1;FBS:胎牛血清;FISH:荧光原位杂交;IHC:免疫组织化学;ISH:原位杂交;lncRNA:长链非编码 RNA;miRNA:microRNA;MUT:突变;NC:阴性对照;OXA:奥沙利铂;PBS:磷酸盐缓冲液;PD:进展性疾病;PFA:多聚甲醛;PR:部分缓解;qPCR:定量聚合酶链反应;RAPA:雷帕霉素;SD:稳定疾病;TEM:透射电子显微镜;WT:野生型。